Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
RESMED INC
Report date August 18, 2017 · Filed August 23, 2017 · Amendment
Section 16 reporting ended · disclosed 2017-08-23. Current position is not established by this disclosure.
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| ResMed Common StockSEC Table I · non-derivative | Direct | 84,633 |
Reported balance
Holding disclosure · report date 2017-08-18 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance 84,633 F1: Includes 203.57 shares of ResMed stock purchased on April 28,2017, through the ResMed Employee Stock Purchase Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 203.57 shares of ResMed stock purchased on April 28,2017, through the ResMed Employee Stock Purchase Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 11, 2016 Filed Nov 14, 2016 15:51 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 2,247 | $59.85 | $134,482.95 |
DisclosureSEC source: 0001140361-16-086062 · doc1.xml · nonDerivative · entry 3 Reiser Anne · CIK 0001544561 · President - ResMed Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,429 F4 · shares: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/19/2015. Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 15:51 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 2,356 | $59.85 | $141,006.60 |
DisclosureSEC source: 0001140361-16-086062 · doc1.xml · nonDerivative · entry 2 Reiser Anne · CIK 0001544561 · President - ResMed Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,677 F3 · shares: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/19/2014. Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 15:51 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 1,899 | $59.85 | $113,655.15 |
DisclosureSEC source: 0001140361-16-086062 · doc1.xml · nonDerivative · entry 1 Reiser Anne · CIK 0001544561 · President - ResMed Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,033 F1 · shares: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/13/2013. F2 · balance_after: Includes 220 shares of ResMed stock purchased on 10/31/2016, through the ResMed Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.